Module 1.3 FDA Negotiations
FDA Negotiations: providing the participant with an understanding of the process by which a REMS Program comes into being, and what to expect from the FDA, and when, in designing a REMS Program for New Drug Applications, Biologic License Applications, and New Molecular Entity Applications.